IGES Pharma at Bio Europe Spring (Virtual Event) on April 30, 2022

The convention "Bio Europe Spring" is one of the leading biotechnology conventions in Europe, the main thematic focus is the development of new biotechnological drugs for human use. The convention has been held for many years, this year it will be conducted virtually.

Dr. Elisabeth Brock from IGES Pharma will moderate a workshop at this convention on April 30. The title of the workshop is: Early Trial Planning in Times of Pay-for-Performance Agreements & European HTA Harmonization.

This workshop will be about innovative reimbursement for high-cost therapies in Europe. It will outline how mid-sized biotech companies can successfully bring their innovations into the European reimbursement systems through early study planning. Special emphasis is placed on the harmonization of the health technology assessment (hta) procedures and the resulting study design requirements. Success factors for pay-for-performance models are also presented.

More information about the workshop can be found here https://informaconnect.com/bioeurope-spring/agenda/4/#therapeutic-area-track_early-trial-planning-in-times-of-pay-for-performance-agreements-european-hta-harmonization_13-30

THE EUROPEAN PHARMACEUTICAL MARKETS AT A GLANCE

Our 65-page guide “Reimbursement and Pricing of Pharmaceuticals in Europe” provides an overview of European pharmaceutical markets and explains the current regulatory, pricing and reimbursement systems of the five largest European countries: Germany, France, Italy, the United Kingdom and Spain.

If you would like a copy of the guide, please email Ms. Agata Daroszewska.

EUROPEAN PHARMACEUTICAL MARKET